Godavari Drugs Limited Share - Company Data & Prices - INE362C01012 | MoneyPeak

Godavari Drugs Limited

Share · INE362C01012 (XBOM)

No Price

Closing Price XBOM 05.02.2026: 89,55 INR

05.02.2026 06:01

Current Prices from Godavari Drugs Limited

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
MSE	GODAVARI.BO	INR	05.02.2026 06:01	89,55 INR	-1,14 INR -1,26 %

Share Float & Liquidity

Free Float 37,62 %

Shares Float 2,83 M

Shares Outstanding 7,53 M

Company Profile for Godavari Drugs Limited Share

Godavari Drugs Ltd. engages in the manufacture of active pharmaceutical ingredients and its intermediates. Its products include Ciprofloxacin Hydrochloride, Enrofloxacin, Centrizine Hydrochloride, Ethambutol Hydrochloride, A D Lactone, and Benzhyryl Piperazine. The company was founded on December 2, 1987 and is headquartered in Secunderabad, India.

AI Analysis of Godavari Drugs Limited

Click any analysis below to get instant AI insights from finAgent

Latest AI Analyses of Godavari Drugs Limited

No AI threads available for this company yet.

Company Data

Name Godavari Drugs Limited

Company Godavari Drugs Limited

Website http://www.godavaridrugs.com

Primary Exchange

MSE

ISIN INE362C01012

Asset Class Share

Sector Healthcare

Industry Medical - Pharmaceuticals

CEO Mukund Kakani

Market Capitalization 697 Mio

Country India

Currency INR

Employees 0,1 T

Address 1-8-303, Secunderabad

Ticker Symbols

Name	Symbol
MSE	GODAVARI.BO

More Shares

Investors who hold Godavari Drugs Limited also have the following shares in their portfolio:

DoubleLine Shiller CAPE U.S. Equities ETF ETF

Response Informatics Limited Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2026